Philippines Department of Justice recommends charges against six Sanofi officials

pharmafile | March 1, 2019 | News story | Medical Communications Philippines, Sanofi, dengue, dengvaxia, vaccines 

The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over the death and injury of hundreds of children and adults relating to a dangerous dengue vaccine.

One hundred and eighteen people, including 115 children and 33 adults, died after receiving Sanofi’s dengue vaccine, Dengvaxia, in 2016 after the Philippines became one of the first countries to use the vaccine in a mass immunisation programme.

The programme was suspended in 2017 after Sanofi announced that the vaccine could make cases of dengue worse in some cases in which patients had had no previous exposure.

The Philippines Department of Justice said in a statement on Friday that it would recommend charges be filed in court for reckless imprudence resulting in homicide, due to what it said were procedural lapses in the implementation of a dengue immunization program in 2016.

The government body recommended charges be filed against six Sanofi officials and 14 current and former Philippines health officials.

Louis Goss

Related Content

CureVac and GSK begin phase 1 trial for mRNA flu vaccine candidates

CureVac and GSK have announced that the first patient in the phase 1 section of …

Maze Therapeutics and Sanofi sign exclusive worldwide license agreement for Pompe disease treatment

Maze Therapeutics and Sanofi have announced that they have signed an exclusive worldwide license agreement …

Sanofi complete acquisition of mRNA company Translate Bio

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal …

Latest content